GEICO Intensifies Crackdown on No-Fault Insurance Fraud Schemes

News desk: Government Employees Insurance Company (GEICO) has ramped up its efforts to combat no-fault auto insurance fraud, filing multimillion-dollar civil lawsuits against medical providers, durable medical equipment suppliers, and affiliated individuals in New York and Florida. These actions highlight the persistent vulnerabilities in the Personal Injury Protection (PIP) systems in both states, where insurers are required to pay medical claims promptly with limited initial scrutiny.

Significant legal developments

In February 2026, GEICO secured a major appellate victory when the US Court of Appeals for the Second Circuit upheld a preliminary injunction in GEICO v. Patel. The ruling allows GEICO to pause over 600 parallel state-court collection lawsuits and arbitrations filed by defendants, while the federal racketeering case proceeds. GEICO alleges that Dr. Bhargav Patel and affiliated clinics submitted approximately $3.4 million in claims between 2019 and 2023 for treatments that were unnecessary, experimental, excessive, illusory, or never provided. The scheme reportedly involved kickbacks for patient steering, brief consultations followed by standardized treatment plans, and services delivered by unlicensed personnel.

The appellate court’s decision provides a potential blueprint for other insurers dealing with similar fraud cases in the no-fault system. By consolidating the dispute into federal court under civil RICO claims, GEICO aims to demonstrate a broad pattern of fraud, which cannot be fairly evaluated on a claim-by-claim basis.

Recent fraud allegations

In late April 2026, GEICO filed a lawsuit in the US District Court for the Eastern District of New York, accusing four medical supply companies- Go For Med Supply Corp., Snyder Med Supplies Corp., Tantemed Supply Corp., and 10 of 10 Med Supply Corp.- of orchestrating a $2.6 million fraud scheme. The insurer claims that the defendants used “paper owners” and a hidden controller who allegedly directed operations through rotating shell entities. Tactics included kickbacks, misrepresented billing codes, and submitting claims for medically unnecessary equipment. GEICO seeks recovery of paid amounts, declaratory relief for outstanding claims exceeding $530,000, treble damages under RICO, and additional remedies.

Earlier, in March 2026, GEICO filed another lawsuit targeting a network of 12 durable medical equipment companies and 10 individuals, accusing them of a $2.9 million fraud scheme. The complaint states that GEICO paid more than $1.4 million on fraudulent bills and is exposed to additional claims. Defendants allegedly billed for unnecessary devices while cycling corporate entities to evade detection.

Fraud allegations in Florida

GEICO has also targeted clinics in Florida, filing suits in April 2026 against several clinics in Tampa, Lakeland, and Riverview, including entities linked to chiropractor Christopher Shane Miller. GEICO claims over $2.3 million in improper billings for complex evaluations, unnecessary therapy, and other treatments related to minor soft-tissue injuries from automobile accidents. Additional claims across Florida and New York brought the total alleged fraud to more than $2.7 million.

In early 2026, GEICO pursued a Florida clinic network accused of operating a $26 million PIP fraud operation across multiple locations.

Systemic issues and common allegations

Across these cases, GEICO highlights several systemic issues in the no-fault insurance system. These include schemes involving patient runners or brokers who receive illegal incentives, nominal medical directors with minimal oversight, and high-volume billing practices disconnected from actual patient needs. Many claims involve soft-tissue injuries from low-impact accidents that trigger standardized protocols for therapy, chiropractic care, diagnostic testing, or equipment, regardless of medical necessity.

The no-fault laws in New York and Florida were designed to ensure swift compensation for accident victims and reduce litigation. However, critics argue that the prompt-payment requirements and direct billing by providers have created an environment ripe for abuse, ultimately driving up premiums for all policyholders. GEICO, like other insurers, has specialized investigative units to identify suspicious patterns such as unusual volume spikes, geographic clustering, or mismatched treatment codes.

Tension between access to care and fraud prevention

These lawsuits underscore the ongoing tension between access to care and fraud prevention. While defendants often argue that treatments were legitimate and that insurers are improperly delaying valid payments, courts have increasingly recognized the harm caused by fragmented litigation when a larger fraudulent enterprise is involved. The Patel ruling, in particular, strengthens insurers’ ability to seek holistic resolution in federal court, preventing an overload of fragmented individual lawsuits.

Regulatory developments and future steps

Industry observers note that successful fraud recoveries and deterrents could help moderate rate pressures. However, the volume of schemes suggests systemic challenges remain. Regulators in New York and Florida continue to examine the no-fault system, with discussions about stronger licensing oversight, fee schedules, and independent medical examinations. Public-private cooperation with agencies like the National Insurance Crime Bureau also plays a key role in combating fraud.

As of early May 2026, most of the recent filings are in preliminary stages, with no final findings of liability. GEICO has declined to comment on active litigation beyond stating its commitment to combating fraud on behalf of policyholders. However, the cases signal that GEICO intends to pursue aggressive civil remedies, including RICO claims that carry the potential for treble damages and attorneys’ fees, to protect the integrity of the no-fault system.